Skip to main content

National Cancer Institute — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

102
Companies
$325.9M
Total invested
$3.4M
Avg. check
22
Industries
Biotechnology 17Medical 11Health Care 10Therapeutics 5Life Science 4Medical Device 3+16 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 73–96 of 102
Ananya Health
September 2024

Ananya Health develops a medical device for treating cervical pre-cancer.

Health Care · San Francisco$2.3M Grant
Voximetry
August 2024

Voximetry is a healthtech software company that aims to give many cancer patients an alternative to chemotherapy.

Biotechnology · Madison$2.0M Grant
Matter Bio
May 2024

Matter Bio operates as company focus on preserving genome integrity.

Biotechnology · New YorkGrant
Microvascular Therapeutics
October 2023

Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.

Biotechnology · Tucson$4.0M Grant
Modifi Bio
October 2023

Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.

Biotechnology · New Haven$4.3M Seed
Saros Therapeutics
September 2023

Saros Therapeutics is working to enhance patients' response to immunotherapy.

Biotechnology · Chicago$2.0M Grant
Current Surgical
August 2023

Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors.

Health Care · WashingtonNon Equity Assistance
Histolix
June 2023

Histolix provides an intrinsically digital and slide-free histopathology solution.

Image Recognition · Sacramento$3.2M Grant
Helocyte
June 2023

Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.

Biotechnology · New York$3.2M Grant
Reveal Pharmaceuticals
May 2023

Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.

Biotechnology · Cambridge$500K Grant
MALCOVA
April 2023

MALCOVA is a medical device startup delivering novel hardware and AI-based software solutions to resolve needs in the radiology market.

Health Diagnostics · Newark$1.0M Grant
Georgia Cancer Center
April 2023

Georgia Cancer Center provides industry-leading cancer research and care that benefits patients locally and globally.

Health Care · Augusta$2.3M Grant
Isabl Inc.
April 2023

Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.

Biotechnology · New York$2.0M Grant
GigaMune
March 2023

GigaMune is a biotech firm focused on engineered TCR-Treg cell therapies for autoimmune diseases, including Type 1 Diabetes.

Biotechnology · San FranciscoSeed
Kovina Therapeutics
November 2022

Kovina Therapeutics operates as a pre-clinical biotechnology company.

Biotechnology · Indianapolis$275K Grant
Oleolive
September 2022

Olive Oil is a biotechnology company that produces extra virgin olive oil.

Biotechnology · Shreveport$400K Grant
Telehealth ReseArch Center of Excellence
August 2022

Telehealth Research Center of Excellence is a cancer center that is engaged in improving cancer-related care and outcomes.

Education · Philadelphia$5.7M Grant
AUM LifeTech
August 2022

AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.

Biotechnology · Philadelphia$400K Grant
Flexomics
July 2022

Flexomics helps to bridge genomic and functional analysis.

Biotechnology · Boston$2.0M Grant
Atrin Pharmaceuticals
July 2022

Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.

Biotechnology · DoylestownSeries A
Immunicom
June 2022

Immunicom is a biotechnology company.

Biotechnology · San Diego$2.0M Grant
InheRET
May 2022

InheRET empowering individuals to accurately identify their risk for hereditary conditions.

Health Care · Ann Arbor$580K Seed
Shasqi
December 2021

Pioneering in-human click chemistry against cancer

Biotechnology · San Francisco$1.9M Grant
TumorGen
August 2021

TumorGen is a biotechnology company.

Biotechnology · San Diego$390K Grant

Where National Cancer Institute invests

Biotechnology17
Medical11
Health Care10
Therapeutics5
Life Science4
Medical Device3

About National Cancer Institute's portfolio

How many companies has National Cancer Institute invested in?▸

National Cancer Institute has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does National Cancer Institute invest in?▸

National Cancer Institute's top investment sectors include Biotechnology, Medical, Health Care, Therapeutics, Life Science. The firm invests across 22 different industry categories.

What is National Cancer Institute's largest investment?▸

Among tracked funding rounds, Telehealth ReseArch Center of Excellence received $5.7M in a Grant round. National Cancer Institute's total known invested capital is $325.9M.

What is the average investment size for National Cancer Institute?▸

National Cancer Institute's average investment size is $3.4M across its portfolio of 102 companies.

What are National Cancer Institute's most recent investments?▸

Recent National Cancer Institute portfolio additions include Ananya Health, Voximetry, Matter Bio, Microvascular Therapeutics, Modifi Bio. These companies were founded in 2020 or later.

Reach the founders behind these 102 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →